encephalitis

FDA accepts priority review for Pfizer’s TicoVac
Pharmaceutical Business Review
Wed, 02/24/21 - 10:53 am
Pfizer
FDA
TicoVac
encephalitis
tick-borne encephalitis
priority review
Biogen, AbbVie yank MS drug Zinbryta off the market in the wake of encephalitis cases
Endpoints
Fri, 03/2/18 - 11:08 am
Biogen
AbbVie
MS
multiple sclerosis
Zinbryta
Europe
encephalitis